Evidence map›Paper›PMID 31482640›Full record

ArticleEMBO reports2019

Codon bias confers stability to human mRNAs.

Fabian Hia, Sheng Fan Yang, Yuichi Shichino, Masanori Yoshinaga, Yasuhiro Murakawa, Alexis Vandenbon, Akira Fukao, Toshinobu Fujiwara, Markus Landthaler, Tohru Natsume and 3 more

Abstract read
In one paragraph

Article in EMBO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. RiboScreenBiomedicines · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. NNature · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases.Molecular therapy. Methods & clinical development · 2025
    Review
  19. Organelle Genomes ofBiology · 2025
    Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fabian HiaDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Sheng Fan YangDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuichi ShichinoRNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Japan.
Masanori YoshinagaDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yasuhiro MurakawaDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Alexis VandenbonLaboratory of Infection and Prevention, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Akira FukaoLaboratory of Biochemistry, Department of Pharmacy, Kindai University, Higashiosaka City, Japan.
Toshinobu FujiwaraLaboratory of Biochemistry, Department of Pharmacy, Kindai University, Higashiosaka City, Japan.
Markus LandthalerRNA Biology and Posttranscriptional Regulation, Max Delbrück Center for Molecular Medicine Berlin, Berlin Institute for Molecular Systems Biology, Berlin, Germany.
Tohru NatsumeMolecular Profiling Research Center for Drug Discovery (molprof), National Institute of Advanced Industrial Science and Technology (AIST), Tokyo, Japan.
Shungo AdachiMolecular Profiling Research Center for Drug Discovery (molprof), National Institute of Advanced Industrial Science and Technology (AIST), Tokyo, Japan.ORCID 0000-0001-5232-411X
Shintaro IwasakiRNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Japan.
Osamu TakeuchiDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-1260-6232

Funding

Pacific Biosciences PacBio RS Single Molecule Real Time SequencerS10OD018174 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI ROKHSAR, DANIEL SOLEYMAN · 2014 to 2014
$600k
Japan Agency for Medical Research and Development JP17gm0410017Joint Usage/Research Center Program of Institute for Frontier Life and Medical SciencesMEXT|Japan Society for the Promotion of Science JSPS 18H05278MEXT|Japan Society for the Promotion of Science JSPS JP17H04998MEXT|Japan Society for the Promotion of Science JSPS JP17H05679NIH HHS S10 OD018174Takeda Science FoundationUehara Memorial Foundation
6 · The paper itself

Abstract

Codon bias has been implicated as one of the major factors contributing to mRNA stability in several model organisms. However, the molecular mechanisms of codon bias on mRNA stability remain unclear in humans. Here, we show that human cells possess a mechanism to modulate RNA stability through a unique codon bias. Bioinformatics analysis showed that codons could be clustered into two distinct groups-codons with G or C at the third base position (GC3) and codons with either A or T at the third base position (AT3): the former stabilizing while the latter destabilizing mRNA. Quantification of codon bias showed that increased GC3-content entails proportionately higher GC-content. Through bioinformatics, ribosome profiling, and in vitro analysis, we show that decoupling the effects of codon bias reveals two modes of mRNA regulation, one GC3- and one GC-content dependent. Employing an immunoprecipitation-based strategy, we identify ILF2 and ILF3 as RNA-binding proteins that differentially regulate global mRNA abundances based on codon bias. Our results demonstrate that codon bias is a two-pronged system that governs mRNA abundance.

Indexed as

CodonCodon UsageComputational BiologyGuanylate CyclaseHumansNuclear Factor 45 ProteinRibosomesRNA, MessengerRNA StabilityTranscription, GeneticCodonGuanylate CyclaseNuclear Factor 45 ProteinRNA, Messengercodon biascodon optimalityGC-contentmRNA stabilitytranslation efficiency

Identifiers

PMID31482640
PMCPMC6831995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.